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THE CURRENT STATE OF CANCER 
DIAGNOSIS
The UK has a poor record on cancer survival: 
international studies such as Eurocare and 
the International Cancer Benchmarking 
Partnership (ICBP) have consistently 
demonstrated that cancer survival rates 
in the UK are significantly worse than in 
other developed countries. For example, in 
data from 2005–2007, only 8.8% of patients 
diagnosed with lung cancer in the UK 
survived for 5 years, compared with 18.4% 
in Canada.1 These differences are thought 
to reflect an increased incidence of cancer 
diagnosed in the UK at a late clinical stage, 
so-called ‘delayed diagnosis’.
The causes of delayed diagnosis of 
cancer in general practice (primary 
care delay) in the UK remain uncertain. 
It has been consistently suggested that 
the ‘gatekeeping’ role of GPs in the UK 
contributes to the problem. When asked 
to consider (fictitious) cases of possible 
cancer, UK GPs were less likely to consider 
immediate investigation or referral than 
doctors from countries with higher survival 
rates.2 However, no good correlation was 
found between gatekeeping and cancer 
survival in an international comparison of 
healthcare systems.3 Relatively poor access 
to CT/MRI and to specialist advice may also 
contribute to the problem in the UK.
Recent data show that cancer survival 
rates in the UK are improving. However, this 
is also true in other countries, such that the 
gap between the UK and best-performing 
countries remains, with one or two notable 
exceptions, such as with breast cancer.
So although research into primary care 
delay continues, we would like to offer 
some practical advice on cancer diagnosis 
for GPs in their everyday practice.
CONSIDER USING CANCER RISK 
PREDICTION TOOLS
There are a number of tools available 
to help predict current or future risk of 
cancer. Evidence of the effect of some 
of these tools has been demonstrated.4 
However, embedding their use into routine 
clinical practice is more challenging and 
will require a deeper understanding of how 
such a complex intervention can become 
normalised.
Cancer Risk Assessment Tool (RAT)
The RAT was circulated by the National 
Cancer Action Team in 2012 based on the 
CAPER studies in Exeter. A separate table 
for each of 15 cancers gives the positive 
predictive value (PPV, %) for that cancer 
from symptoms present either singly or 
in pairwise combination. The values are 
colour-coded for risk. Several studies have 
demonstrated the utility of the RATs.5
QCancer
This is an online tool (www.qcancer.org) 
that calculates the current risk of cancer 
(PPV) at 12 organ sites based on both risk 
factors and clinical features. A separate 
tool exists for males and females. Risk is 
automatically calculated for all cancers 
in the algorithm, which may help in the 
diagnosis of cancer type.
Macmillan Cancer Decision Support (CDS) 
tools
These tools utilise both the RAT and 
QCancer but extend their use into additional 
functions in GP IT systems. For example, a 
‘prompt’ feature calculates the risk of six 
major cancers (lung, colorectal, ovarian, 
pancreatic, renal, oesophagogastric) for 
any patient whose record is being used, 
and alerts the user if any risk >2% is 
identified. A risk stratification tool can be 
applied to the whole practice population, 
or sub-groups thereof, to identify high-
risk patients who may not have identified 
clinically.
What remains unknown about risk 
prediction tools is patient and professional 
acceptability, how they can be incorporated 
into routine clinical practice, and their 
clinical and economic impact.4 However, 
we recommend that GPs should consider 
these tools for their own clinical practice.
BE AWARE OF RECURRENT THEMES IN 
DELAYED DIAGNOSIS OF CANCER
A number of recurrent themes arise from 
research and audit of primary care delay 
in cancer diagnosis. Described below are 
those that we believe to be most relevant, 
including, where appropriate, advice to GPs 
on how to avoid them.
Persistent or recurrent infection
The classical example is an ‘acute 
exacerbation of chronic obstructive 
pulmonary disease’ being treated with 
repeated courses of antibiotics and steroids 
while actually representing a lung cancer.6 
In theory well recognised, this scenario 
continues to appear in significant event 
audits of lung cancer. Recurrent urine 
infection due to underlying bladder cancer 
is another example.7 In such situations, we 
suggest that GPs should always establish 
1) when antibiotics were last used; and 
2) whether the patient recovered in the 
meantime. If the patient is re-presenting 
with the same episode of ‘infection’, further 
investigation should be considered.
Constant pain
Most pain, especially of musculoskeletal 
origin, varies with time, position, and 
movement. Constant pain should alert the 
GP to a possible malignancy and should 
be investigated. For example, constant 
posterior shoulder pain in a smoker may 
represent a lung cancer. Pain, most 
commonly in the shoulder, lower back, or 
groin, may also be a presenting feature of 
metastatic disease.8
Unusual age at diagnosis
Young age. ‘My doctor told me I was too 
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young for cancer’ is a recurrent comment 
in media accounts of delayed diagnosis. 
Moreover, the incidence of (non-hereditary) 
colorectal cancer in under-50s is increasing 
rapidly.9 We advise GPs to avoid excluding 
cancer solely on the basis of young age.
Older age. New diagnoses that usually 
have a young onset, in older patients, 
should be treated with caution. Examples 
include migraine, irritable bowel syndrome, 
and mechanical back pain. GPs should 
avoid any such diagnoses made on clinical 
features only; investigations are warranted.
Infrequent attenders
Patients who have previously only rarely 
attended the surgery have an increased 
risk of cancer on presentation compared 
with more frequent attenders.10 GPs should 
have a lower threshold for investigation in 
such patients.
False-negative investigations
The classical example is chest X-ray that 
has a sensitivity of only approximately 
75% in lung cancer.11 If significant clinical 
suspicion exists, GPs should continue to 
pursue a cancer diagnosis, even if initial 
investigations are normal.
Safety netting
Good safety netting has repeatedly been 
demonstrated to be of vital importance 
in preventing primary care delay.12 GPs 
should remember that this applies to other 
members of the primary care team and 
also to systems of working. For example, 
if a patient presenting with new prostatic 
symptoms misses a nurse appointment 
for a PSA, what, if any, system does the 
practice have to follow this up?
LOOKING FORWARD
In addition to the above advice, significantly 
improving early diagnosis of cancer in UK 
general practice may require a change 
in culture. Traditionally, GPs have tended 
to use a combination of guidelines and 
clinical judgement to try to identify cases 
of symptomatic cancer to be referred 
on to secondary care for appropriate 
management. A high ‘conversion rate’ 
(the proportion of referrals subsequently 
diagnosed as cancer) has been considered 
to reflect good skills in cancer detection 
but conversely may be articulating delay in 
diagnosis. Recent data comparing cancer 
outcomes between localities demonstrates 
the latter. Good cancer outcomes correlate 
with high referral rates but not high 
conversion rates.13
With the National Institute for Health and 
Care Excellence’s 2015 Suspected Cancer 
guidelines recommending urgent referral at 
a PPV of 3% (less in some circumstances),14 
and with the availability of population risk 
tools, the role of GPs in cancer diagnosis 
should be clarified. Is identification of 
symptomatic cases via clinical judgement 
sufficient, or should a wider approach, for 
example, using population risk tools, be 
used to detect additional cases?
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